Home > Industrial Machinery > Industrial Equipment > Cryogenic Equipment > medical cold chain storage equipment market
Get a free sample of Medical Cold Chain Storage Equipment Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Medical Cold Chain Storage Equipment Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
In 2023, key companies like Azenta, Binder, Haier Biomedical, Hoshizaki America and Memmert held a combined market share of 8%-10%. These companies are actively engaging in mergers, acquisitions, facility expansions, and collaborations to enhance their product portfolios, reach more customers, and strengthen their market positions. Companies are investing in Internet of Things (IoT) and smart technologies for real-time monitoring and data logging, improving operational efficiency and regulatory compliance. The increasing focus on sustainability is prompting businesses to develop energy-efficient and environmentally friendly cold chain solutions, which influences their market position.
Major companies operating in the global medical cold chain storage equipment industry include:
Key players in the global medical cold chain storage equipment market encompass Azenta, Binder, Cardinal Health, Carebios Biological Technology, Darwin Chambers, Elanpro, Farrar, Haier Biomedical, Hoshizaki America, Kendall Cold Chain System, Memmert, Philipp Kirsch, Roemer Industries, Summit Appliance, and Thalheimer Kuhlung.
North America led the global medical cold chain storage equipment market with a share of about 32% in 2023 and is projected to witness around 5.4% CAGR up to 2032. This growth can be attributed to the rising demand for vaccines and biologics, an expanding healthcare infrastructure, ongoing R&D investments, and technological advancements in storage solutions.
In 2023, the pharmaceutical segment held approximately 33% of the market share and is projected to witness a CAGR of 5.6% through 2032, led by pharmaceutical manufacturers increasingly embracing advanced cold chain technologies for the production and storage of temperature-sensitive drugs, notably biologics and vaccines.
In 2023, the medical cold chain storage equipment industry surpassed USD 2.9 billion and is projected to grow at a CAGR of 5.3% from 2024 to 2032. This growth is fueled by the surging demand for vaccines and biologics.
The freezers segment was reached USD 1.1 billion in 2023 and is projected to grow at a 5.9% CAGR from 2024 to 2032, driven by rising demand for Ultra-Low Temperature Freezers, especially for storing mRNA vaccines that require very low temperatures.